Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
242.06 USD | -0.35% | +1.95% | +3.30% |
Jan. 22 | UBS Adjusts Price Target on Ecolab to $257 From $260, Keeps Neutral Rating | MT |
Jan. 10 | Ecolab Well-Positioned for Future Growth, Faces Short-Term Challenges, RBC Says | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 14.91B | 11.79B | 12.73B | 14.19B | 15.32B | |||||
Total Revenues | 14.91B | 11.79B | 12.73B | 14.19B | 15.32B | |||||
Cost of Goods Sold, Total | 8.68B | 6.86B | 7.52B | 8.76B | 9.13B | |||||
Gross Profit | 6.22B | 4.93B | 5.21B | 5.43B | 6.19B | |||||
Selling General & Admin Expenses, Total | 3.87B | 3.25B | 3.34B | 3.58B | 4B | |||||
Other Operating Expenses, Total | 3.87B | 3.25B | 3.34B | 3.58B | 4B | |||||
Operating Income | 2.35B | 1.68B | 1.87B | 1.85B | 2.18B | |||||
Interest Expense, Total | -215M | -221M | -198M | -252M | -349M | |||||
Interest And Investment Income | 24.1M | 14.6M | 12.3M | 8.5M | 52.2M | |||||
Net Interest Expenses | -191M | -206M | -185M | -244M | -297M | |||||
Other Non Operating Income (Expenses) | 2M | -4.3M | -1.6M | -1M | 2.7M | |||||
EBT, Excl. Unusual Items | 2.16B | 1.47B | 1.68B | 1.6B | 1.89B | |||||
Restructuring Charges | -139M | -79.1M | -36.6M | -107M | -85.7M | |||||
Merger & Related Restructuring Charges | -13.4M | -13.1M | -34.9M | -39.5M | -16.1M | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | -107M | -220M | -195M | -114M | -32.1M | |||||
EBT, Incl. Unusual Items | 1.9B | 1.16B | 1.41B | 1.34B | 1.76B | |||||
Income Tax Expense | 323M | 177M | 270M | 234M | 362M | |||||
Earnings From Continuing Operations | 1.58B | 985M | 1.14B | 1.11B | 1.39B | |||||
Earnings Of Discontinued Operations | - | -2.17B | - | - | - | |||||
Net Income to Company | 1.58B | -1.19B | 1.14B | 1.11B | 1.39B | |||||
Minority Interest | -17.3M | -17.4M | -14.1M | -17.2M | -20.7M | |||||
Net Income - (IS) | 1.56B | -1.21B | 1.13B | 1.09B | 1.37B | |||||
Net Income to Common Incl Extra Items | 1.56B | -1.21B | 1.13B | 1.09B | 1.37B | |||||
Net Income to Common Excl. Extra Items | 1.56B | 967M | 1.13B | 1.09B | 1.37B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 5.41 | -4.2 | 3.95 | 3.83 | 4.82 | |||||
Basic EPS - Continuing Operations | 5.41 | 3.37 | 3.95 | 3.83 | 4.82 | |||||
Basic Weighted Average Shares Outstanding | 288M | 287M | 286M | 285M | 285M | |||||
Net EPS - Diluted | 5.33 | -4.15 | 3.91 | 3.81 | 4.79 | |||||
Diluted EPS - Continuing Operations | 5.33 | 3.33 | 3.91 | 3.81 | 4.79 | |||||
Diluted Weighted Average Shares Outstanding | 292M | 290M | 289M | 287M | 286M | |||||
Normalized Basic EPS | 4.62 | 3.15 | 3.62 | 3.46 | 4.07 | |||||
Normalized Diluted EPS | 4.55 | 3.11 | 3.59 | 3.44 | 4.05 | |||||
Dividend Per Share | 1.85 | 1.89 | 1.95 | 2.06 | 2.16 | |||||
Payout Ratio | 35.6 | -46.54 | 50.13 | 55.22 | 44.98 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.32B | 2.5B | 2.71B | 2.79B | 3.11B | |||||
EBITA | 2.67B | 1.9B | 2.11B | 2.17B | 2.49B | |||||
EBIT | 2.35B | 1.68B | 1.87B | 1.85B | 2.18B | |||||
EBITDAR | 3.54B | 2.68B | 2.89B | 2.98B | 3.32B | |||||
Total Revenues (As Reported) | 14.91B | 11.79B | 12.73B | 14.19B | 15.32B | |||||
Effective Tax Rate - (Ratio) | 16.99 | 15.21 | 19.11 | 17.46 | 20.65 | |||||
Current Domestic Taxes | 135M | -43.9M | 30.9M | 146M | 138M | |||||
Current Foreign Taxes | 225M | 260M | 240M | 231M | 280M | |||||
Total Current Taxes | 360M | 216M | 271M | 377M | 418M | |||||
Deferred Domestic Taxes | 32.7M | 12M | 3.6M | -78.9M | -40.1M | |||||
Deferred Foreign Taxes | -70.4M | -51.3M | -4.5M | -63.7M | -15M | |||||
Total Deferred Taxes | -37.7M | -39.3M | -900K | -143M | -55.1M | |||||
Normalized Net Income | 1.33B | 903M | 1.04B | 986M | 1.16B | |||||
Non-Cash Pension Expense | -54.5M | -49M | -37.1M | -26.9M | -62.2M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 209M | 185M | 186M | 190M | 192M | |||||
Net Rental Expense, Total | 219M | 184M | 179M | 197M | 215M | |||||
Imputed Operating Lease Interest Expense | 54.02M | 46.64M | 34.85M | 43.68M | 67.7M | |||||
Imputed Operating Lease Depreciation | 165M | 137M | 145M | 153M | 148M | |||||
Stock-Based Comp., Other (Total) | 91.1M | 82.1M | 89.5M | 87.8M | 95.1M | |||||
Total Stock-Based Compensation | 91.1M | 82.1M | 89.5M | 87.8M | 95.1M |